Explore India's urgent need to bridge the healthcare gap for children with Type 1 Diabetes (T1D) by ensuring universal access ...
Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by CDSCO, Afrezza offers a convenient way to manage diabetes, especially for ...
Cipla Ltd. launched #InhaleTheChange, a campaign to improve insulin adherence by addressing emotional and practical barriers.
Cipla Ltd. today launched its nationwide awareness initiative, #InhaleTheChange, aimed at encouraging better insulin adherence through empowerment, and destigmatization. These efforts reflect Cipla's ...
Roche Diabetes Care India (RDC India) announced that their blood glucose monitoring device ‘Accu-Chek Active’ is now manufactured in India. This move is a part of the company's strategy to improve ...
Novo Nordisk, a Who's Who in the pharmaceutical industry, has now made public that it has officially launched, for medical use, its blockbuster diabetes medication, Ozempic (Semaglutide), in India.
Nick Jonas, who was diagnosed with type 1 diabetes when he was 13 years old in 2002, co-founded the diabetes non-profit Beyond Type 1 10 years ago. Nick and board member Priyanka Chopra Jonas and ...
A few years ago, the women of Mehma Sawai village in Punjab were struggling with their health. The Primary Health Centre was ...
India Today on MSN
I've been a diabetes specialist for 50 years, here's what I know about sugar spikes
A look into top diabetologist Dr. V. Mohan's lifestyle, his journey in medicine and what he has learnt about sugar spikes.
News-Medical.Net on MSN
Diabetes could drain up to INT$78.8 trillion from the global economy by 2050, study finds
This global macroeconomic analysis estimates that diabetes mellitus will cost the world economy INT$10.2 trillion between ...
Diabetes scares me. It haunts me. I lost my father to diabetes in the 1980s, when I was still a kid in India. I grew up watching my mother boil glass syringes and reuse metal needles for his insulin ...
The diabetes management mobile applications segment is projected to grow at the highest CAGR during the forecast period. The report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results